These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 21254339
1. Meeting report of the 16th Annual International Congress of the International Liver Transplantation Society. Levitsky J, Guckelberger O. Liver Transpl; 2011 Jan; 17(1):10-4. PubMed ID: 21254339 [No Abstract] [Full Text] [Related]
2. [Recurrence of hepatitis B and C after liver transplantation]. Duclos-Vallée JC. Rev Prat; 2011 Jan; 61(1):61-4. PubMed ID: 21452545 [No Abstract] [Full Text] [Related]
3. Meeting report of the 2014 joint international congress of the International Liver Transplantation Society, Liver Intensive Care Group of Europe, and European Liver and Intestinal Association. Diaz G, Levitsky J, Oniscu G. Liver Transpl; 2015 Jul; 21(7):991-1000. PubMed ID: 25857840 [Abstract] [Full Text] [Related]
6. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report. Nakamura Y, Hama K, Iwamoto H, Yokoyama T, Kihara Y, Konno O, Jojima Y, Shimazu M. Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070 [Abstract] [Full Text] [Related]
7. Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis. Vasavada BB, Chan CL. Exp Clin Transplant; 2015 Feb; 13(1):46-50. PubMed ID: 25654412 [Abstract] [Full Text] [Related]
9. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation. Lee EC, Kim SH, Lee SD, Park H, Lee SA, Park SJ. World J Gastroenterol; 2016 Apr 14; 22(14):3803-12. PubMed ID: 27076765 [Abstract] [Full Text] [Related]
12. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. Vivarelli M, Dazzi A, Zanello M, Cucchetti A, Cescon M, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD. Transplantation; 2010 Jan 27; 89(2):227-31. PubMed ID: 20098287 [Abstract] [Full Text] [Related]
14. Preoperative administration of 5-FU and interferon beta may prevent recurrence of hepatitis B and C virus. Sato Y, Ichida T, Ito S, Hatakeyama K. Am J Gastroenterol; 2002 Jan 27; 97(1):215-6. PubMed ID: 11808961 [No Abstract] [Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. Fahrner R, Dondorf F, Ardelt M, Dittmar Y, Settmacher U, Rauchfuß F. World J Gastroenterol; 2015 Nov 14; 21(42):12071-82. PubMed ID: 26576092 [Abstract] [Full Text] [Related]
19. Salvage live donor liver transplantation for a second recurrence of hepatocellular carcinoma. Sotiropoulos GC, Treckmann JW, Molmenti EP, Schmitz KJ, Cicinnati VR, Paul A, Broelsch CE, Malagó M. Transpl Int; 2008 Feb 14; 21(2):182-5. PubMed ID: 17971034 [No Abstract] [Full Text] [Related]